Nuveen LLC Purchases New Shares in Agilent Technologies, Inc. $A

Key Points

• Nuveen LLC acquired 287,128 shares of Agilent Technologies in Q1, valued at approximately $33.6 million, marking their entry into the company.
• Agilent Technologies reported quarterly earnings of $1.31 per share, exceeding estimates by $0.05, with a revenue of $1.67 billion, reflecting a 6% increase year-over-year.
• Agilent announced a quarterly dividend of $0.248 per share, resulting in an annualized yield of 0.8%, with a payout ratio of 24.44%.

Nuveen LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 287,128 shares of the medical research company's stock, valued at approximately $33,588,000. Nuveen LLC owned 0.10% of Agilent Technologies as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Whipplewood Advisors LLC lifted its stake in shares of Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after buying an additional 186 shares during the period. Sunbelt Securities Inc. increased its position in Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Opal Wealth Advisors LLC acquired a new position in Agilent Technologies during the first quarter worth approximately $31,000. Wood Tarver Financial Group LLC acquired a new position in Agilent Technologies during the fourth quarter worth approximately $34,000. Finally, Zions Bancorporation National Association UT acquired a new position in Agilent Technologies during the first quarter worth approximately $38,000.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. UBS Group dropped their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Robert W. Baird dropped their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Finally, Leerink Partners upped their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday, May 30th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and an average price target of $139.77.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Trading Down 1.7%

Shares of Agilent Technologies stock traded down $2.0330 during trading hours on Thursday, hitting $117.0770. The company's stock had a trading volume of 744,650 shares, compared to its average volume of 1,327,447. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The business has a fifty day moving average of $117.79 and a 200 day moving average of $117.65. The company has a market capitalization of $33.26 billion, a PE ratio of 28.91, a P/E/G ratio of 3.61 and a beta of 1.22. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.05. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The business's quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.22 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.